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Abstract Insulin stimulation of Glut 4 translocation requires
the activation of phosphatidylinositol 3-kinase (PI 3-kinase) but
the downstream pathway remains ill-defined. We demonstrated
that the overexpression of PDK1 (3-phosphoinositide-dependent
protein kinase 1), a downstream effector of PI 3-kinase,
stimulated Glut 4 translocation in adipocytes. This effect does
not require the PH domain of PDK1, but expression of the
pleckstrin homology domain-deleted PDK1 inhibits the effect of
insulin, but not okadaic acid, on Glut 4 translocation. These
results support a role of the PDK1 pathway in the transmission
of insulin signal to Glut translocation.
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1. Introduction
In muscle and adipose cells insulin involves the transloca-
tion of speci¢c vesicles containing the glucose transporter
Glut 4 from an intracellular storage compartment to the plas-
ma membrane [1]. It is now well established that phosphati-
dylinositol 3-kinase (PI 3-kinase) activation is required for this
insulin e¡ect. Indeed, expression of a constitutively active
form of PI 3-kinase mimics insulin e¡ects on Glut 4 trans-
location [2^4] while inhibition of PI 3-kinase activity prevents
this translocation [5^7]. However, it is unclear how activation
of PI 3-kinase relays the insulin signal to Glut 4 translocation.
The protein serine/threonine kinase B (PKB) and the atypical
protein kinases C V or j (aPKC) have been shown to be
downstream e¡ectors of PI 3-kinase. Activation of these ki-
nases requires their phosphorylation on both threonine 308 and
serine 473 for PKB and threonine 410 for PKC j by the
serine/threonine kinase PDK1 (3-phosphoinositide-dependent
protein kinase 1) [8,9]. PDK1, like PKB, possesses a pleckstrin
homology (PH) domain which binds phosphatidylinositol 3,4-
bisphosphate (PtdIns(3,4)P2) or phosphatidylinositol 3,4,5-tri-
phosphate (PtdIns(3,4,5)P3) and which is involved in the reg-
ulation of PDK1 localization and/or activity [10^12]. How-
ever, it is not clear whether PDK1 and its downstream
e¡ectors, PKD or aPKC, are involved in Glut 4 translocation.
Indeed, both constitutively active forms of PKB [4,13] or PKC
V/j [14^16] increase Glut 4 translocation in adipocytes and
3T3-L1 adipocytes. However, some studies show that domi-
nant negative mutants of PKB inhibit insulin-induced Glut 4
translocation [17,18] while our studies found no e¡ect of these
mutated forms of PKB [19] or found that dominant negative
mutants of PKC V/j inhibit glucose transporter translocation
[14^16].
In this paper we assess the role of the PDK1 pathway in
Glut 4 translocation in freshly isolated adipocytes. Our results
indicate that overexpression of PDK1 partially mimics the
insulin e¡ect and that a mutated form of PDK1 deleted of
its PH domain prevents insulin stimulation of Glut 4 trans-
location. We propose that PDK1 plays a role in the regulation
of insulin-stimulated Glut 4 translocation.
2. Materials and methods
2.1. Antibodies
Monoclonal antibody to the HA epitope (clone 12CA5) was pur-
chased from Roche Diagnostics (Meylan, France). Antibody against
the myc epitope was raised in rabbits with the peptide AEEQKLI-
SEEEDLLK coupled to keyhole limpet hemocyanin. Puri¢ed Ig was
obtained by a⁄nity chromatography.
2.2. Mammalian expression vectors
2.2.1. pCIS Glut 4 myc. pCIS is an expression vector containing a
cytomegalovirus promoter and enhancer with a generic intron located
upstream of the multiple cloning site (a gift of Genentech). The cDNA
encoding rat Glut 4 with the myc epitope inserted in the ¢rst exofacial
loop (Glut 4 myc) was subcloned into this vector as previously de-
scribed [20].
2.2.2. pSG HA-PKB. The cDNA encoding bovine PKBK (a gift of
Dr. Co¡er, Utrecht, The Netherlands) was subcloned into the mam-
malian expression vector pSG5. The protein was tagged at the NH2-
terminus with an in£uenza virus hemagglutinin epitope.
2.2.3. pCMV5 PDK1myc and pCMV5 vPH PDK1myc. PDK1 (a
gift of Dr. Alessi, Dundee, UK) cloned from the human MCF7
cDNA library was subcloned into the vector pCMV5. vPH PDK1
was obtained by deleting the PH domain of PDK1 and was subcloned
into the pCMV5 vector. Both proteins were tagged at their NH2-
terminus with a myc epitope.
Plasmid DNAs were obtained using a maxi kit (Qiagen SA, Cour-
teboeuf, France), and their concentrations were determined by meas-
uring the OD at 260 nm.
2.3. Measurement of PKB activity
Adipose cells were isolated from epididymal and perirenal fad pats
of fed male Wistar rats (200^220 g) by collagenase digestion. Adipo-
cytes were transfected by electroporation using a double electric shock
with 1 Wg of pSG HA-PKB and 10 Wg of pCMV5 PDK1myc [4]. After
16^20 h, electroporated adipocytes were washed twice, resuspended as
a 20% (v/v) suspension in Krebs-Ringer bicarbonate bu¡er containing
30 mM HEPES, pH 7.4 (KRBH) and 1% (w/v) bovine serum albumin
(BSA) and incubated for 10 min at 37‡C with or without 100 nM
insulin. After washing, cells were solubilized for 45 min at 4‡C in 20
mM Tris pH 7.4, 150 mM NaCl, 10 mM EDTA, 2 mM sodium
orthovanadate, 100 mM NaF, 10 mM Na4P2O7, containing a pro-
tease inhibitor cocktail (Complete Roche Diagnostics, Meylan,
France). Lysates were centrifuged for 15 min at 13 000Ug and pro-
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teins (150^200 Wg) were incubated with monoclonal anti-HA antibod-
ies coupled to protein G Sepharose beads. After 3 h at 4‡C, the beads
were washed three times with 25 mM HEPES pH 7.4, 0.1% BSA, 10%
glycerol, 1% Triton, 1 M NaCl and twice with 20 mM Tris pH 7.4, 10
mM MgCl2, 0.5 mM DTT. Assay for PKB activity was performed on
the immune pellet using Crosstide as a substrate [21].
2.4. Assay for cell surface epitope-tagged Glut 4 measurement
Adipocytes were co-transfected by electroporation with pCIS Glut 4
myc (1 Wg) and with pCMV5 PDK1myc (10 Wg) or pCMV5 vPH
PDK1myc (10 Wg). 16^20 h following the transfection, they were
resuspended as a 10% (v/v) suspension in KRBH bu¡er containing
1% (w/v) BSA. Cells were then incubated for 30 min at 37‡C in the
absence or presence of 100 nM insulin. Following insulin stimulation,
adipose cells were treated with 2 mM potassium cyanide to prevent
Glut 4 redistribution. The level of cell surface Glut 4 myc was deter-
mined using rabbit antibodies to the myc epitope in conjunction with
125I-radiolabeled protein A [4]. Radioactivity was normalized by
measuring protein concentration in each sample using the bicincho-
ninic acid assay (Pierce, Rockford, IL, USA). Cells transfected with
empty vector alone were used to determine non-speci¢c binding,
which represented 30% of the total binding observed in cells trans-
fected with pCIS Glut 4 myc in the absence of insulin stimulation.
This value was subtracted from all values.
3. Results and discussion
To test whether overexpression of PDK1myc activates
PKB, freshly isolated adipocytes were cotransfected with
pSG HA-PKB and pCMV5 PDK1myc and were treated or
not with insulin before the measurement of HA-PKB activity
using Crosstide as a substrate. Insulin induced a 8^9-fold in-
crease in PKB activity in cells transfected with pSG HA-PKB
alone (Fig. 1A, control). PDK1myc overexpression partially
activates PKB and insulin treatment did not further increase
this activity compared to the insulin-treated control cells (Fig.
1A). This result is in agreement with previous data showing
that overexpression of PDK1 in 293 cells induces only the
phosphorylation of PKB on its threonine 308 and its partial
activation [10]. Indeed, phosphorylation of both threonine 308
and serine 473 was necessary for the full activation of PKB
[22^24]. To study whether PDK1 could play a role in Glut 4
translocation, adipocytes were transfected with pCIS Glut 4
myc and pCMV5 PDK1myc, and the amount of Glut 4 myc
at the plasma membrane was measured by the binding of an
anti-myc antibody to the intact cells. This approach makes it
possible to determine speci¢cally the amount of transporters
at the cell surface of transfected adipocytes. In control cells,
expressing Glut 4 myc alone, insulin induced a 4-fold increase
in the amount of Glut 4 myc at the cell surface (Fig. 1B). In
the absence of insulin stimulation, PDK1 overexpression in-
creased the number of Glut 4 myc at the plasma membrane by
2-fold compared to control cells (Fig. 1B). Following insulin
stimulation, the amount of Glut 4 myc at the cell surface was
similar in control adipocytes or in PDK1-transfected adipo-
cytes. These results show that an increase in PDK1 activity
partially mimics the e¡ect of insulin. It has been reported that
the PH domain of PDK1 could play a role in the activation
and/or the localization of the protein [10^12] leading us to
study the e¡ect of the deletion of this domain on the ability
of PDK1 to stimulate Glut 4 translocation. Adipocytes were
transfected by electroporation with pCIS Glut 4 myc alone
(Fig. 2, control) or in combination with pCMV5 vPH
PDK1myc (Fig. 2, vPH-PDK1). As shown in Fig. 2, vPH
PDK1 expression induced an increase in Glut 4 translocation
in the absence of insulin stimulation indicating that the PH
domain of PDK1 is not necessary for this e¡ect. It has been
shown that PDK1 without its PH domain phosphorylates
PKB on threonine 308 leading to a partial activation of this
protein [10]. This could explain why the expression of vPH
PDK1 partly stimulates Glut 4 translocation. Interestingly,
while expression of vPH PDK1 per se stimulated Glut 4
translocation, it markedly reduced the insulin-stimulated
Glut 4 translocation (Fig. 2). This e¡ect is not due to a change
in Glut myc expression (data not shown) and seems speci¢c
for insulin since vPH PDK1 expression did not modify the
e¡ect of okadaic acid (Fig. 2), an inhibitor of protein phos-
phatase 2A, which stimulates glucose transport and PKB ac-
tivity independently of the PI 3-kinase/PDK1 pathway [21,25].
These data suggest that the PH domain of PKD1 is required
to allow the insulin stimulation of Glut 4 translocation and
that vPH PDK1 behaves as a dominant negative mutant
which interferes with the insulin signaling pathway. A recent
report demonstrated that PDK1 can also phosphorylate PKB
on its serine 473 but, unlike its threonine 308 phosphorylating
activity, this serine phosphorylation was increased by
PtdIns(3,4,5)P3 production suggesting that the PH domain
was required [26]. It is thus conceivable that vPH PDK1
could not phosphorylate PKB on serine 473 and prevent the
Fig. 1. PDK1 overexpression promotes PKB activation and Glut 4
myc translocation in adipocytes. A: Adipocytes were transfected as
described in Section 2 with pSG HA-PKB alone (CONTROL) or in
combination with pCMV5 PKD1myc. After 24 h, cells were incu-
bated for 10 min in the absence (open bars) or presence (hatched
bars) of insulin (100 nM). HA-PKB was immunoprecipitated with
anti-HA antibodies, and kinase assays were performed on immune
pellets as described in Section 2. Results are expressed as fold in-
duction and represent the mean þ S.E.M. of ¢ve independent experi-
ments. B: Adipocytes were transfected with pCIS Glut 4 myc alone
(CONTROL) or in combination with pCMV5 PDK1myc. After
24 h, cells were incubated without (open bars) or with (hatched
bars) 100 nM insulin for 30 min. The amount of Glut 4 myc at the
cell surface was measured by the binding of antibodies to the myc
epitope as described in Section 2. Results are expressed as percent
of insulin stimulation. Values are presented as the mean þ S.E.M. of
six independent experiments.
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serine 473 phosphorylation of endogenous PKB by insulin.
The mechanism of this e¡ect remains to be determined. How-
ever, since it has been shown that PDK1 can form a complex
with its downstream e¡ectors such as PKC j/V [27], it would
be possible that overexpressed vPH PDK1, by titrating these
proteins, could blunt their activation.
In summary, our results show that the PDK1 pathway is
involved in the insulin-induced translocation of Glut 4. Fur-
ther the PH domain of PDK1 seems necessary for the insulin
stimulation of this translocation.
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Fig. 2. vPH PDK1 expression inhibits insulin-stimulated Glut 4
myc translocation in adipocytes. Isolated adipocytes were trans-
fected with pCIS Glut 4 myc alone (CONTROL) or in combination
with pCMV5 PDK1myc. Twenty-four hours after transfection, cells
were treated without (open bars) or with (hatched bars) 100 nM in-
sulin or with 1 WM okadaic acid (gray bars) for 30 min. The
amount of Glut 4 myc present at the cell surface was measured by
binding of antibodies to the myc epitope. Results are expressed in
percent of insulin e¡ect and represent the mean þ S.E.M. of six inde-
pendent experiments.
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